2型糖尿病患者糖尿病肾病患病率及其危险因素分析

doi:10.12183/j.scjpm.2021.0228

Abstract

CLC Number:

R195

References 28

[1]	Xu Y, Wang L, He J, et a1. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
[2]	余珊, 王波. 糖尿病健康教育研究进展[J]. 昆明医科大学学报, 2018, 39(4):130-134.
[3]	王永胜, 杨丽霞, 程涛, 等. 糖尿病肾病的炎症致病机制与中药防治[J]. 中国实验方剂学杂志, 2018, 24(2):208-215.
[4]	杨倩, 关天俊. 糖尿病肾病的诊治进展[J]. 世界临床药物, 2018, 39(2):93-97.
[5]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志, 2014, 30(8):893-942.
[6]	中华人民共和国卫生部疾病控制司.中国成年人超重和肥胖症预防控制指南[M]. 北京:人民卫生出版社, 2006:3-8.
[7]	中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007,19(5):4-14.
[8]	中华医学会内分泌学分会. 中国成人糖尿病肾脏病临床诊断的专家共识[J]. 中华内分泌代谢杂志, 2015, 31(5):379-385.
[9]	Kowalski A, Krikorian A, Lerma EV.Diabetes and chronic kidney disease[J]. Dis Mon, 2015, 61(9):378-386.
[10]	刘琳, 卓莉. 糖尿病肾病病程演变的新认识[J]. 国际泌尿系统杂志, 2019, 39(6):1149-1151.
[11]	Jadawji C, Crasto W, Gillies C, et al.Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta analysis[J]. Diabetes Obes Metab, 2019, 21(3):658-673.
[12]	张艳军. 2型糖尿病患者发生糖尿病肾病的危险因素分析及中医预防对策[J]. 中国卫生检验杂志, 2019, 29(1):75-77.
[13]	罗加凯, 李志红,尹飞, 等. 糖尿病肾病的临床特征及其危险因素研究[J]. 临床荟萃, 2017, 32(9):763-766.
[14]	段丽君, 王健, 韩静, 等. 天津市2型糖尿病慢性并发症流行病学研究[J]. 重庆医学, 2019, 48(22):3874-3878.
[15]	徐梅华, 蔡克银. 2 型糖尿病患者踝臂指数与糖尿病肾病的关系研究[J]. 实用预防医学, 2012, 19(9):1418-1420.
[16]	王鲁伃. 2型糖尿病合并早期糖尿病肾病的相关危险因素分析[J]. 影像研究与医学应用, 2018, 2(5):209-211.
[17]	UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes[J]. BMJ, 1998, 317(7160):703-713.
[18]	林虹,郑循达,魏余琴,等.雅安市2型糖尿病患者血糖控制达标情况及其影响因素[J].华南预防医学,2020,46(6):626-629.
[19]	魏明燕,王国杰,苏虹虹.2型糖尿病患者血糖控制情况与HbA1c、25-羟维生素D、脂肪代谢的关系[J].中国热带医学,2018,18(2):173-175.
[20]	翁洁,黄晓云,曹娟.2型糖尿病患者糖尿病视网膜病变的发生情况及影响因素调查[J].华南预防医学,2020,46(6):609-612.
[21]	王植, 刘聪, 邱阳, 等. 甲状腺激素与糖尿病肾病关系的研究进展[J]. 山东医药, 2019, 59(34):96-99.
[22]	雷永富, 李敏. 住院2型糖尿病患者甲状腺激素与慢性肾脏病检出率的关系[J]. 临床内科杂志, 2019, 36(12):819-822.
[23]	中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识( 2014 年版)[J] .中国糖尿病杂志, 2014, 6(11):792-801.
[24]	Hill CJ, Cardwell CR, Patterson CC, et al.Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit[J]. Diabetic Medicine,2014, 31(4): 448-454.
[25]	胡颖辉, 陈宏, 杨锐, 等广东省超重肥胖2型糖尿病患者糖尿病肾病的患病率及危险因素分析[J]. 中国现代医学杂志, 2016, 26(23):89-94.
[26]	吴雪静, 孟令宇, 赵沙沙, 等. 2 型糖尿病发生糖尿病肾病的相关危险因素探讨[J]. 华北理工大学学报:医学版, 2016,18(6): 458-461.
[27]	Chen HC, Guh JY, Shin SJ, et al.Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein[J]. Kidney Int Suppl, 2001, 78:124-127.
[28]	Li Y, Wu QH, Jiao ML, et al.Gene -environment interaction between adiponectin gene polymorphisms and environmental factors on the risk of diabetic retinopathy[J]. J Diabetes Invest, 2014, 6(1): 56-66.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	YAN Chun, GONG Yuan, HUANG Ping, CHEN Juan, HUANG Miao. Early poor prognosis and predictive model construction in patients with acute ischemic stroke [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1213-1217.
[2]	XU Yan, WANG Xuexia, HAN Chunling. Characteristics and influencing factors of polypoid lesion of gallbladder in adult residents of Dongying City [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1224-1228.
[3]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1294-1297.
[4]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1305-1308.
[5]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1327-1329.
[6]	JING Leilei, WANG Yating, YANG Yong, LI Yajie, ZHAO Haiying, LI Huifang, LI Zhanpeng. Influencing factors of knee osteoarthritis in people ≥ 40 years old in Zhangjiakou area [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1078-1082.
[7]	WANG Shijian, CHEN Zelun, ZHENG Jingjing, XU Ying. Analysis of the incidence and influencing factors of retinopathy in elderly patients with hypertension [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1098-1102.
[8]	ZHAO Xiaohong, XU Shanshan, HAN Yuzhou, HUANG Haisha, SUN Jingjing. Status and influencing factors of adverse pregnancy outcomes in pregnant women with gestational diabetes mellitus in Langfang City [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1109-1113.
[9]	LI Nannan, HUANG Limin, ZHANG Xiaohua. Incidence and risk factors of major adverse cardiovascular events in patients with acute coronary syndrome within 1 year after discharge [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1119-1123.
[10]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1180-1183.
[11]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1188-1191.
[12]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1205-1208.
[13]	YAN Yongfeng, XU Yuanyou, WANG Jun, CHEN Yongsheng, ZHANG Yonghui, DING Lulu, CHEN Jianguo, FAN Jian, ZHU Jian. Trend analysis of brain tumor survival rate in Qidong City, Jiangsu Province, 1972 - 2016 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 960-964.
[14]	LUO Chengli, LIU Fangjing, PENG Xiang, LI Shimei, WU Qiaohui, MAO Li, DONG Yuan, SUN Xianfu, LI Shuangle. Prevalence and influencing factors of cataract among the elderly in Zigong City [J]. South China Journal of Preventive Medicine, 2023, 49(8): 990-994.
[15]	FAN Hailong, NIU Yanbin, GUO Zhenshan, AN Qianjiang, WANG Xiumei. Association between visceral adiposity index and blood glucose variation in Chinese middle-aged and elderly prediabetic population： a cohort study [J]. South China Journal of Preventive Medicine, 2023, 49(7): 803-807.